Soru

Zorluk: OrtaDepressive Disorders

A 28-year-old woman is diagnosed with major depressive disorder and prescribed an oral selective serotonin reuptake inhibitor (SSRI). Arrange the following clinical events and milestones in the typical chronological order in which they are expected to occur during her treatment course, from the initial days of therapy to long-term management.

  1. 1Onset of early medication side effects, such as gastrointestinal upset and mild agitation.
  2. 2Improvement in physical neurovegetative symptoms, such as sleep, appetite, and energy levels.
  3. 3Window of highest risk for suicidal actions due to increased physical energy without corresponding mood elevation.
  4. 4Maximal therapeutic response with significant relief of subjective depressed mood and anhedonia.
  5. 5Initiation of the continuation phase of pharmacotherapy to prevent symptom relapse.

Cevap

The correct sequence begins with immediate side effects, followed by neurovegetative symptom improvement, a period of heightened suicide risk, delayed mood improvement, and finally the continuation phase.
The established clinical timeline for SSRI treatment involves immediate onset of side effects (days 1-7), followed by early improvement in neurovegetative symptoms like energy and sleep (weeks 1-2). Because energy returns before mood improves, patients experience a critical window of increased suicide risk during this mismatch. Finally, core mood symptoms and anhedonia remit (weeks 4-6), allowing the patient to enter the continuation phase of treatment (months 2-8).

Adım Adım Çözüm

1
Identify the immediate effects of starting an SSRI.
Gastrointestinal upset and agitation occur within days.
Serotonergic side effects precede therapeutic benefits due to immediate receptor activation.
2
Determine the first depressive symptoms to improve.
Neurovegetative symptoms (sleep, energy, appetite) improve within 1 to 2 weeks.
Physical and vegetative symptoms respond faster than core psychological symptoms.
3
Assess the clinical consequence of mismatched symptom improvement.
A period of elevated suicide risk occurs.
Patients gain the energy to act on suicidal ideation before their subjective mood and hopelessness improve.
4
Identify the timeline for core symptom resolution.
Mood and anhedonia improve after 4 to 6 weeks.
Receptor downregulation and downstream neurogenesis require several weeks to produce emotional recovery.
5
Determine the next phase of treatment after achieving remission.
The continuation phase begins.
Clinical guidelines recommend 4 to 9 months of continued treatment post-remission to prevent relapse.

Anahtar Kavram

Timeline of clinical response and side effects for antidepressant pharmacotherapy
Bu soruyu puanla